|
CRNX Crinetics Pharmaceuticals Inc 1658247 |
| Balance Sheet |
|
Current Assets
|
877,587,000 |
|
Assets
|
937,374,000 |
|
Current Liabilities
|
53,562,000 |
|
Liabilities
|
104,394,000 |
|
Equity
|
832,980,000 |
|
Shares Out
|
80,036,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-161,296,000 |
|
Investing Cash Flow
|
-32,729,000 |
| Market Analysis |
Market Cap
|
4,213,474,725 |
|
Price
|
37.35 |
|
BVPS
|
10.41 |
|
PB
|
3.59 |
|
EPS
|
-3.77 |
|
PS
|
4.15 |
|
FCF
|
-194,025,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CRNX documents filed with the SEC.
CRNX Filings
Clear
